{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:59:51Z","timestamp":1781614791208,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003010","name":"Ege University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). MF patients with neoplasms had a higher average age and older age at MF diagnosis (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.003 and 0.016, respectively). Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.\n                  <\/jats:p>","DOI":"10.1007\/s00277-025-06442-7","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T22:00:59Z","timestamp":1750111259000},"page":"3829-3836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7507-6999","authenticated-orcid":false,"given":"Ayda","family":"Acar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-9292","authenticated-orcid":false,"given":"Ayris","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-4116","authenticated-orcid":false,"given":"Gunseli","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-3935","authenticated-orcid":false,"given":"Ilgen Ertam","family":"Sagduyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-4199","authenticated-orcid":false,"given":"Bengu Gerceker","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2915-0788","authenticated-orcid":false,"given":"Banu","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0866-8913","authenticated-orcid":false,"given":"Taner","family":"Akal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"6442_CR1","doi-asserted-by":"publisher","first-page":"151546","DOI":"10.1016\/j.anndiagpath.2020.151546","volume":"47","author":"A Alsayyah","year":"2020","unstructured":"Alsayyah A (2020) Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol 47:151546. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151546","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"6442_CR2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/jdv.17384","volume":"35","author":"A Goyal","year":"2021","unstructured":"Goyal A, O\u2019Leary D, Goyal K, Rubin N, Janakiram M (2021) Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, hodgkin lymphoma, lung cancer, bladder cancer and melanoma. J Eur Acad Dermatol Venereol 35(9):1821\u20131829. https:\/\/doi.org\/10.1111\/jdv.17384","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"6442_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/ddg.14400","volume":"19","author":"A Scheu","year":"2021","unstructured":"Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS (2021) Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas. J Dtsch Dermatol Ges 19(3):373\u2013381. https:\/\/doi.org\/10.1111\/ddg.14400","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"6442_CR4","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.jaad.2020.06.1033","volume":"85","author":"A Goyal","year":"2021","unstructured":"Goyal A, O\u2019Leary D, Goyal K, Patel K, Pearson D, Janakiram M (2021) Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer. J Am Acad Dermatol 85(6):1418\u20131428. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.1033","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"6442_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.4274\/tjh.2017.0234","volume":"34","author":"FP Cengiz","year":"2017","unstructured":"Cengiz FP, Emiro\u011flu N, Onsun N (2017) Frequency and risk factors for secondary malignancies in patients with mycosis fungoides. Turk J Haematol 34(4):378\u2013379. https:\/\/doi.org\/10.4274\/tjh.2017.0234","journal-title":"Turk J Haematol"},{"issue":"19","key":"6442_CR6","doi-asserted-by":"publisher","first-page":"adv00346","DOI":"10.2340\/00015555-3704","volume":"100","author":"S Sherman","year":"2020","unstructured":"Sherman S, Kremer N, Dalal A, Solomon-Cohen E, Berkovich E, Noyman Y et al (2020) Melanoma risk is increased in patients with mycosis fungoides compared with patients with psoriasis and the general population. Acta Derm Venereol 100(19):adv00346. https:\/\/doi.org\/10.2340\/00015555-3704","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"6442_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jdcr.2020.06.029","volume":"6","author":"TS Bhat","year":"2020","unstructured":"Bhat TS, Rosman IS, Cornelius LA, Musiek AC (2020) Mycosis fungoides associated with recurrence of malignant melanoma. JAAD Case Rep 6(8):793\u2013795. https:\/\/doi.org\/10.1016\/j.jdcr.2020.06.029","journal-title":"JAAD Case Rep"},{"issue":"2","key":"6442_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jaad.2019.07.075","volume":"83","author":"A Goyal","year":"2020","unstructured":"Goyal A, O\u2019Leary D, Goyal K, Rubin N, Bohjanen K, Hordinsky M et al (2020) Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A surveillance, epidemiology, and end results analysis. J Am Acad Dermatol 83(2):404\u2013411. https:\/\/doi.org\/10.1016\/j.jaad.2019.07.075","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"6442_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaad.2019.06.037","volume":"82","author":"A Goyal","year":"2020","unstructured":"Goyal A, O\u2019Leary D, Goyal K, Rubin N, Bohjanen K, Hordinsky M et al (2020) Increased risk of second primary malignancies in patients with mycosis fungoides: a single-center cohort study. J Am Acad Dermatol 82(3):736\u2013738. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.037","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"6442_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jaad.2019.11.051","volume":"83","author":"R Almukhtar","year":"2020","unstructured":"Almukhtar R, Gill F, Soine R, McBurney E (2020) Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and S\u00e9zary syndrome. J Am Acad Dermatol 83(2):647\u2013648. https:\/\/doi.org\/10.1016\/j.jaad.2019.11.051","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"6442_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5114\/ada.2021.106205","volume":"38","author":"I B\u0142a\u017cewicz","year":"2021","unstructured":"B\u0142a\u017cewicz I, Olszewska B, Stawczyk-Macieja M, Ja\u015bkiewicz M, Nowicki RJ, Soko\u0142owska-Wojdy\u0142o M (2021) The incidences of other primary cancers in patients with mycosis fungoides and S\u00e9zary syndrome. Postepy Dermatol Alergol 38(2):289\u2013294. https:\/\/doi.org\/10.5114\/ada.2021.106205","journal-title":"Postepy Dermatol Alergol"},{"issue":"2","key":"6442_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3816\/CLM.2008.n.011","volume":"8","author":"I Brownell","year":"2008","unstructured":"Brownell I, Etzel CJ, Yang DJ, Taylor SH, Duvic M (2008) Increased malignancy risk in the cutaneous T-cell lymphoma patient population. Clin Lymphoma Myeloma 8(2):100\u2013105. https:\/\/doi.org\/10.3816\/CLM.2008.n.011","journal-title":"Clin Lymphoma Myeloma"},{"issue":"8","key":"6442_CR13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/1097-0142(19890415)63:8<1612::aid-cncr2820630828>3.0.co;2-c","volume":"63","author":"AF Kantor","year":"1989","unstructured":"Kantor AF, Curtis RE, Vonderheid EC, van Scott EJ, Fraumeni JF Jr (1989) Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 63(8):1612\u20131615. https:\/\/doi.org\/10.1002\/1097-0142(19890415)63:8<1612::aid-cncr2820630828>3.0.co;2-c","journal-title":"Cancer"},{"key":"6442_CR14","unstructured":"Willemze R (2018) Cutaneous T-cell lymphoma. In: Bolognia JL, Schaffer JV, Cerroni L (eds) Dermatology, 4th edn. Elsevier, pp 2127\u20132145"},{"issue":"4","key":"6442_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.23736\/S2784-8671.19.06510-6","volume":"156","author":"A Pileri","year":"2021","unstructured":"Pileri A, Guglielmo A, Fuligni F, Lastrucci I, Patrizi A, Pimpinelli N et al (2021) Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? Ital J Dermatol Venerol 156(4):484\u2013488. https:\/\/doi.org\/10.23736\/S2784-8671.19.06510-6","journal-title":"Ital J Dermatol Venerol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06442-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06442-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06442-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:37:58Z","timestamp":1781613478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06442-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6442"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06442-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ege University Faculty of Medicine Research Ethics Committee (No. 20-10.1T\/34, Date: 15.10.2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participants prior to inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The article is original and has not been published or submitted elsewhere.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Originality"}}]}}